Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation

Author:

Cho Hyun-Jai123,Lee Choon-Soo1,Kwon Yoo-Wook13,Paek Jae Seung1,Lee Sun-Hee1,Hur Jin1,Lee Eun Ju13,Roh Tae-Young4,Chu In-Sun5,Leem Sun-Hee6,Kim Youngsoo7,Kang Hyun-Jae123,Park Young-Bae123,Kim Hyo-Soo1238

Affiliation:

1. National Research Laboratory for Cardiovascular Stem Cell,

2. Cardiovascular Center and Department of Internal Medicine, and

3. Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul;

4. Division of Integrative Biosciences and Biotechnology, Division of Molecular and Life Sciences, Pohang University of Science and Technology, Pohang;

5. Medical Genomics Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon;

6. Department of Biological Science, Dong-A University, Busan;

7. Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul; and

8. Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Seoul, Korea

Abstract

Abstract The concept of reprogramming of somatic cells has opened a new era in regenerative medicine. Transduction of defined factors has successfully achieved pluripotency. However, during the generation process of induced pluripotent stem (iPS) cells, genetic manipulation of certain factors may cause tumorigenicity, which limits further application. We report that that a single transfer of embryonic stem (ES) cell–derived proteins into primarily cultured adult mouse fibroblasts, rather than repeated transfer or prolonged exposure to materials, can achieve full reprogramming up to the pluripotent state without the forced expression of ectopic transgenes. During the process, gene expression and epigenetic status were converted from somatic to ES-equivalent status. We verified that protein-based reprogramming was neither by the contamination of protein donor ES cell nor by DNA/RNA from donor ES cell. Protein-iPS cells were biologically and functionally very similar to ES cells and differentiated into 3 germ layers in vitro. Furthermore, protein-iPS cells possessed in vivo differentiation (well-differentiated teratoma formation) and development (chimeric mice generation and a tetraploid blastocyst complementation) potentials. Our results provide an alternative and safe strategy for the reprogramming of somatic cells that can be used to facilitate pluripotent stem cell–based cell therapy.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 195 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3